Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Nov 2019 – Jan 2025Where it's discussed
-
X / Twitter175 posts
-
News20 articles
-
Facebook11 posts
-
YouTube2 videos
-
Blogs2 articles
AI synopsis
What people are saying
The discussions emphasize crucial aspects of the new guidelines, including mentions of the high costs associated with treating drug-resistant TB, with statements like 'it can cost over $500,000 to treat the most drug-resistant form of TB.' Additionally, users signal high interest with phrases like 'NEW guidelines for treatment' and calls to review them, indicating a collective urgency to understand and implement these recommendations. The tone is largely supportive, with many contributors recognizing the importance of these guidelines in addressing a worsening public health issue.
There is a general consensus among the discussions that the guidelines are a positive addition to the treatment of drug-resistant tuberculosis.
Many participants expressed strong interest, as evidenced by the numerous references to the guidelines and calls for further discussion.
While the discussions are primarily informative, they occasionally delve into specific aspects of the treatments recommended, suggesting moderate engagement.
The perception of significant impact is evident, particularly in discussions around the staggering treatment costs and the complex nature of drug-resistant TB care.
Abstract in brief
- The American Thoracic Society, CDC, European Respiratory Society, and IDSA released a guideline for treating drug-resistant tuberculosis (DRTB), focusing on multidrug-resistant TB (MDRTB) and isoniazid-resistant strains.
- The guideline is based on extensive systematic reviews and data from over 12,000 patients across 50 studies, addressing various treatment strategies and outcomes through a rigorous GRADE methodology.
- Key recommendations include developing effective oral regimens for MDRTB, determining the appropriate choice and duration of medications, and considering surgical options for treatment, all while recognizing the limitations of the underlying evidence.
Top posts
Most liked on X and BlueskyThe NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInfo. Review them here: https://t.co/cHtU8oMAzx https://t.co/ekIjYcSAcz
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/txDJmUJiMl #OpenAccess https://t.co/Xko05IRadT
Treatment of Drug-Resistant Tuberculosis. An Official @atscommunity/@CDCgov/@EuroRespSoc /@IDSAInfo Clinical Practice Guideline: https://t.co/xw2TeoI5NN #MDR-TB
The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInfo. Review them here: https://t.co/cHtU8oMAzx https://t.co/KSNYAx7wcN
Tratamiento de #TB-MDR Guideline ATS/CDC/ERS/IDSAT | American Journal of Respiratory and Critical Care Medicine https://t.co/5lqybLqniJ
All mentions
Advanced Management Strategies for Drug-Resistant Tuberculosis
This video presents clinical insights on tuberculosis management, focusing on treatment and control protocols. It explores diagnostic methods, case studies, and strategic recommendations from clinical guidelines on…
New Guidelines for Treating Drug-Resistant Tuberculosis
New guidelines have been released for treating drug-resistant tuberculosis (DRTB) including multidrug-resistant strains. Access the link for comprehensive recommendations on effective oral regimens, medication choices…
RT @AmbrizMau: Estrategia clínica para la formulación de un régimen de tratamiento individualizado para la TUBERCULOSIS MULTIDROGO-RESISTEN…
RT @AmbrizMau: Resumen de recomendaciones para el uso de fármacos en los regímenes de tratamiento para pacientes con TUBERCULOSIS MULTIDROG…
@NoLockdownLeft @LuisMateusRocha @ggreenwald https://t.co/HxGIENvNdi WHO recommendations https://t.co/spKSbQ7Inp Research article https://t.co/dbCekpCqiz Qualitative experience from someone who underwent treatment here in US.
RT @BIDMC_IDFellows: 6/ Potentially resistant LTBI and treatment ATS/CDC/ERS/IDSA Guidelines: https://t.co/cNzScOwHar https://t.co/Q40sMr5…
6/ Potentially resistant LTBI and treatment ATS/CDC/ERS/IDSA Guidelines: https://t.co/cNzScOwHar https://t.co/Q40sMr5YmC
New2Trip: Treatment of Drug-Resistant Tuberculosis. Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/Fruq6rFrOk
New2Trip: Treatment of Drug-Resistant Tuberculosis. Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/9RuXe3Sz0M
New2Trip: Treatment of Drug-Resistant Tuberculosis. Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/Fruq6rFrOk
New2Trip: Treatment of Drug-Resistant Tuberculosis. Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/9RuXe3AXCc
New2Trip: Treatment of Drug-Resistant Tuberculosis. Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/9RuXe3Sz0M
New2Trip: Treatment of Drug-Resistant Tuberculosis. Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/Fruq6rFrOk
New2Trip: Treatment of Drug-Resistant Tuberculosis. Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/9RuXe3Sz0M
RT @ATSBlueEditor: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/txDJmUJi…
New2Trip: Treatment of Drug-Resistant Tuberculosis. Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/oNtxCLLV7r
Erratum: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/i1eDXN7C2I #SoMe4MV from ATSBlueEditor
New2Trip: Treatment of Drug-Resistant Tuberculosis. Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/VGGWhcBe98
RT @tripdatabase: New2Trip: Treatment of Drug-Resistant Tuberculosis. Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/VG…
New2Trip: Treatment of Drug-Resistant Tuberculosis. Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/VGGWhcBe98
New2Trip: Treatment of Drug-Resistant Tuberculosis. Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/VGGWhcBe98
New #treatment guidelines for drug resistant #TB. Read the guidelines to discover more. #Tuberculosis #TBDiagnostics #InfectiousDisease https://t.co/PNTvvGznco https://t.co/FMsSNbvgVQ
New2Trip: Treatment of Drug-Resistant Tuberculosis https://t.co/hGdzuXwEIU
Treating and curing drug-resistant TB is complicated and inappropriate management can have life-threatening results. CDC, @atscommunity, @IDSA, and @EuroRespSociety published new guidelines for the treatment of #drugresistant #TB. https://t.co/CAwctHikhu https://t.co/UB7ORb8o2n
New2Trip: Treatment of Drug-Resistant Tuberculosis https://t.co/hGdzuXwEIU
New2Trip: Treatment of Drug-Resistant Tuberculosis https://t.co/8aOJGxHszo
New2Trip: Treatment of Drug-Resistant Tuberculosis https://t.co/hGdzuXwEIU
New2Trip: Treatment of Drug-Resistant Tuberculosis https://t.co/8aOJGxHszo
New2Trip: Treatment of Drug-Resistant Tuberculosis https://t.co/hGdzuXwEIU
New2Trip: Treatment of Drug-Resistant Tuberculosis https://t.co/8aOJGxHszo
#DYK it can cost over $500,000 to treat the most drug-resistant form of #TB? Review the guidelines for treatment of drug-resistant #TB: https://t.co/G1aFeHLM1Z https://t.co/35RkGEnuF7
New2Trip: Treatment of Drug-Resistant Tuberculosis https://t.co/hGdzuXwEIU
New2Trip: Treatment of Drug-Resistant Tuberculosis https://t.co/8aOJGxHszo
New2Trip: Treatment of Drug-Resistant Tuberculosis https://t.co/hGdzuXwEIU
New2Trip: Treatment of Drug-Resistant Tuberculosis https://t.co/hGdzuXwEIU
RT @SEIMC_: Tratamiento de #TB-MDR Guideline ATS/CDC/ERS/IDSAT | American Journal of Respiratory and Critical Care Medicine https://t.co/5l…
RT @SEIMC_: Tratamiento de #TB-MDR Guideline ATS/CDC/ERS/IDSAT | American Journal of Respiratory and Critical Care Medicine https://t.co/5l…
RT @SEIMC_: Tratamiento de #TB-MDR Guideline ATS/CDC/ERS/IDSAT | American Journal of Respiratory and Critical Care Medicine https://t.co/5l…
RT @SEIMC_: Tratamiento de #TB-MDR Guideline ATS/CDC/ERS/IDSAT | American Journal of Respiratory and Critical Care Medicine https://t.co/5l…
RT @SEIMC_: Tratamiento de #TB-MDR Guideline ATS/CDC/ERS/IDSAT | American Journal of Respiratory and Critical Care Medicine https://t.co/5l…
RT @SEIMC_: Tratamiento de #TB-MDR Guideline ATS/CDC/ERS/IDSAT | American Journal of Respiratory and Critical Care Medicine https://t.co/5l…
RT @SEIMC_: Tratamiento de #TB-MDR Guideline ATS/CDC/ERS/IDSAT | American Journal of Respiratory and Critical Care Medicine https://t.co/5l…
RT @SEIMC_: Tratamiento de #TB-MDR Guideline ATS/CDC/ERS/IDSAT | American Journal of Respiratory and Critical Care Medicine https://t.co/5l…
RT @SEIMC_: Tratamiento de #TB-MDR Guideline ATS/CDC/ERS/IDSAT | American Journal of Respiratory and Critical Care Medicine https://t.co/5l…
RT @SEIMC_: Tratamiento de #TB-MDR Guideline ATS/CDC/ERS/IDSAT | American Journal of Respiratory and Critical Care Medicine https://t.co/5l…
RT @SEIMC_: Tratamiento de #TB-MDR Guideline ATS/CDC/ERS/IDSAT | American Journal of Respiratory and Critical Care Medicine https://t.co/5l…
RT @SEIMC_: Tratamiento de #TB-MDR Guideline ATS/CDC/ERS/IDSAT | American Journal of Respiratory and Critical Care Medicine https://t.co/5l…
RT @SEIMC_: Tratamiento de #TB-MDR Guideline ATS/CDC/ERS/IDSAT | American Journal of Respiratory and Critical Care Medicine https://t.co/5l…
RT @SEIMC_: Tratamiento de #TB-MDR Guideline ATS/CDC/ERS/IDSAT | American Journal of Respiratory and Critical Care Medicine https://t.co/5l…
Tratamiento de #TB-MDR Guideline ATS/CDC/ERS/IDSAT | American Journal of Respiratory and Critical Care Medicine https://t.co/5lqybLqniJ
RT @ATSBlueEditor: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/txDJmUJi…
RT @ATSBlueEditor: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/txDJmUJi…
RT @CDC_TB: #ICYMI the NEW guidelines for the treatment of drug-resistant #TB are out! Review them here: https://t.co/cHtU8oMAzx https://t.…
RT @CDC_TB: #ICYMI the NEW guidelines for the treatment of drug-resistant #TB are out! Review them here: https://t.co/cHtU8oMAzx https://t.…
RT @jbb4jbb4: Treatment of Drug-Resistant TB. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline. https://t.co/nLleiWk3Gu
#ICYMI the NEW guidelines for the treatment of drug-resistant #TB are out! Review them here: https://t.co/cHtU8oMAzx https://t.co/piewX1wPgg
Treatment of Drug-Resistant TB. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline. https://t.co/nLleiWk3Gu
New recommendations are made for the choice and number of drugs in a regimen, the duration of intensive and continuation phases, and the role of injectable drugs for MDR-TB https://t.co/QPZsQuTMFN
Publicada nueva guía IDSA: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/QPZsQuTMFN
RT @khalideljaaly:
RT @ATSBlueEditor: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/txDJmUJi…
RT @ATSBlueEditor: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/txDJmUJi…
RT @ATSBlueEditor: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/txDJmUJi…
RT @ATSBlueEditor: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/txDJmUJi…
RT @ATSBlueEditor: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/txDJmUJi…
RT @ATSBlueEditor: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/txDJmUJi…
RT @ATSBlueEditor: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/txDJmUJi…
RT @ATSBlueEditor: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/txDJmUJi…
RT @ATSBlueEditor: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/txDJmUJi…
RT @ATSBlueEditor: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/txDJmUJi…
RT @ATSBlueEditor: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/txDJmUJi…
RT @ATSBlueEditor: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/txDJmUJi…
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/txDJmUJiMl #OpenAccess https://t.co/Xko05IRadT
RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInf…
RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInf…
RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInf…
RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInf…
RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInf…
RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInf…
RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInf…
The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInfo. Review them here: https://t.co/cHtU8oMAzx https://t.co/ekIjYcSAcz
RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInf…
RT @martinluga: Guia Tratamiento de la Tuberculosis Multiresisitente, un problema cada vez más frecuente // Treatment of Drug-Resistant Tub…
RT @hrkz1985: 多剤耐性結核の治療ガイドラインが出てます。Dropboxに入れて、いつでも見られるようにしておきます。通読は、厳しいなー。 https://t.co/bGN8MmPG5w
RT @hrkz1985: 多剤耐性結核の治療ガイドラインが出てます。Dropboxに入れて、いつでも見られるようにしておきます。通読は、厳しいなー。 https://t.co/bGN8MmPG5w
多剤耐性結核の治療ガイドラインが出てます。Dropboxに入れて、いつでも見られるようにしておきます。通読は、厳しいなー。 https://t.co/bGN8MmPG5w
RT @martinluga: Guia Tratamiento de la Tuberculosis Multiresisitente, un problema cada vez más frecuente // Treatment of Drug-Resistant Tub…
Guia Tratamiento de la Tuberculosis Multiresisitente, un problema cada vez más frecuente // Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice #tuberculosis #Health #Salud Guideline https://t.co/e0aMiApBjR https://t.co/msqIud3vEK
RT @ATS_BSHSR: Treatment of #Drug- #Resistant #Tuberculosis. An Official #ATS / #CDC / #ERS / #IDSA Clinical Practice Guideline. @ATSBlueEd…
RT @ATS_BSHSR: Treatment of #Drug- #Resistant #Tuberculosis. An Official #ATS / #CDC / #ERS / #IDSA Clinical Practice Guideline. @ATSBlueEd…
RT @alishehri1400: #TB #صوت_الطبيب #صوت_الصيدلي #AntimicrobialResistance Treatment of MDR -TB New guideline https://t.co/FUBbaP4JqT Nice t…
#Clinicians: Do you have questions about how to treat drug-resistant #TB? Review the NEW guidelines for treatment of drug-resistant #TB: https://t.co/cHtU8oMAzx https://t.co/aRH2D47dMX
RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInf…
RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInf…
RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInf…
RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInf…
RT @atscommunity: RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublica…
RT @atscommunity: RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublica…
RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInfo. Review them here: https://t.co/zwdcXOabgh https://t.co/LOS4Wh32k9
RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInf…
RT @ATS_BSHSR: Treatment of #Drug- #Resistant #Tuberculosis. An Official #ATS / #CDC / #ERS / #IDSA Clinical Practice Guideline. @ATSBlueEd…
RT @WMidsMedsInfo: New ATS/CDC/ERS/IDSA Clinical Practice Guideline: Treatment of Drug-Resistant #Tuberculosis. For low-incidence, higher-r…
New ATS/CDC/ERS/IDSA Clinical Practice Guideline: Treatment of Drug-Resistant #Tuberculosis. For low-incidence, higher-resource countries; prioritising all-oral treatment. https://t.co/s8H9rbKeOY #AntimicrobialResistance #EBM See also NICE TB guideline: https://t.co/wmDr4bkMrH
RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInf…
#TB #صوت_الطبيب #صوت_الصيدلي #AntimicrobialResistance Treatment of MDR -TB New guideline https://t.co/FUBbaP4JqT Nice table
Treatment of #Drug- #Resistant #Tuberculosis. An Official #ATS / #CDC / #ERS / #IDSA Clinical Practice Guideline. @ATSBlueEditor #TB #DR-#TB https://t.co/SDr7I1iy1U https://t.co/dUqRTYfNb7
RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInf…
RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInf…
RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInf…
RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInf…
RT @CDC_TB: The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInf…
The NEW guidelines for the treatment of drug-resistant #TB are sponsored by @atscommunity @CDCgov @ERSpublications and @IDSAInfo. Review them here: https://t.co/cHtU8oMAzx https://t.co/KSNYAx7wcN
RT @CDC_TB: #DYK it can cost over $500,000 to treat the most drug-resistant form of #TB? Review the NEW guidelines for treatment of drug-re…
It’s finally here: "Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline." https://t.co/pMdYfVaitc We acknowledge the hard work of the co-authors including those at @CDC and the #TB Centers of Excellence. https://t.co/l91cMErsjb
RT @AmbrizMau: Estrategia clínica para la formulación de un régimen de tratamiento individualizado para la TUBERCULOSIS MULTIDROGO-RESISTEN…
RT @onnmin: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline | American Journal of Respir…
#DYK it can cost over $500,000 to treat the most drug-resistant form of #TB? Review the NEW guidelines for treatment of drug-resistant #TB: https://t.co/cHtU8oMAzx #USAAW19 #BeAntibioticsAware https://t.co/auQhR1waUv
RT @AmbrizMau: Estrategia clínica para la formulación de un régimen de tratamiento individualizado para la TUBERCULOSIS MULTIDROGO-RESISTEN…
RT @AmbrizMau: Estrategia clínica para la formulación de un régimen de tratamiento individualizado para la TUBERCULOSIS MULTIDROGO-RESISTEN…
Treatment of Drug-Resistant Tuberculosis An Official ATS/CDC/ERS/IDSA https://t.co/VLxqlPX5NE
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/0rTPEsVM8F
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/oPJqN4P20H
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/1cZAN8Ipyu
RT @khalideljaaly:
New! Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline @atscommunity @CDCgov @ERSpublications @IDSAInfo https://t.co/r8vulFisn0 https://t.co/aTvOjMtB3j https://t.co/h2mNhVPSdF
RT @atscommunity: Treatment of Drug-Resistant Tuberculosis. An Official @atscommunity/@CDCgov/@EuroRespSoc /@IDSAInfo Clinical Practice Gui…
RT @khalideljaaly:
RT @khalideljaaly:
RT @khalideljaaly:
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline | American Journal of Respiratory and Critical Care Medicine https://t.co/Clp4Zj5AbI
RT @khalideljaaly:
RT @atscommunity: Treatment of Drug-Resistant Tuberculosis. An Official @atscommunity/@CDCgov/@EuroRespSoc /@IDSAInfo Clinical Practice Gui…
Guía ATS/CDC/IDSA para tratamiento de #Tb MDR: #EndTB:
RT @khalideljaaly:
RT @khalideljaaly:
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/3kvtXrebTr
RT @khalideljaaly:
RT @atscommunity: RT @ATSPeds: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t…
RT @onnmin: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline | American Journal of Respir…
RT @onnmin: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline | American Journal of Respir…
RT @onnmin: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline | American Journal of Respir…
RT @atscommunity: Treatment of Drug-Resistant Tuberculosis. An Official @atscommunity/@CDCgov/@EuroRespSoc /@IDSAInfo Clinical Practice Gui…
RT @SimonTiberi: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline | American Journal of R…
RT @onnmin: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline | American Journal of Respir…
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline | American Journal of Respiratory and Critical Care Medicine https://t.co/Gih9OUTk0T
RT @atscommunity: Treatment of Drug-Resistant Tuberculosis. An Official @atscommunity/@CDCgov/@EuroRespSoc /@IDSAInfo Clinical Practice Gui…
RT @khalideljaaly:
RT @SimonTiberi: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline | American Journal of R…
RT @khalideljaaly:
RT @SimonTiberi: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline | American Journal of R…
RT @SimonTiberi: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline | American Journal of R…
RT @SimonTiberi: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline | American Journal of R…
RT @atscommunity: Treatment of Drug-Resistant Tuberculosis. An Official @atscommunity/@CDCgov/@EuroRespSoc /@IDSAInfo Clinical Practice Gui…
RT @atscommunity: Treatment of Drug-Resistant Tuberculosis. An Official @atscommunity/@CDCgov/@EuroRespSoc /@IDSAInfo Clinical Practice Gui…
RT @atscommunity: Treatment of Drug-Resistant Tuberculosis. An Official @atscommunity/@CDCgov/@EuroRespSoc /@IDSAInfo Clinical Practice Gui…
RT @atscommunity: RT @ATSPeds: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t…
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline | American Journal of Respiratory and Critical Care Medicine https://t.co/YzpUvdODOH
RT @khalideljaaly:
RT @atscommunity: RT @ATSPeds: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t…
RT @khalideljaaly:
RT @khalideljaaly:
RT @atscommunity: Treatment of Drug-Resistant Tuberculosis. An Official @atscommunity/@CDCgov/@EuroRespSoc /@IDSAInfo Clinical Practice Gui…
RT @atscommunity: RT @ATSPeds: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t…
RT @atscommunity: Treatment of Drug-Resistant Tuberculosis. An Official @atscommunity/@CDCgov/@EuroRespSoc /@IDSAInfo Clinical Practice Gui…
RT @atscommunity: Treatment of Drug-Resistant Tuberculosis. An Official @atscommunity/@CDCgov/@EuroRespSoc /@IDSAInfo Clinical Practice Gui…
RT @atscommunity: Treatment of Drug-Resistant Tuberculosis. An Official @atscommunity/@CDCgov/@EuroRespSoc /@IDSAInfo Clinical Practice Gui…
RT @atscommunity: RT @ATSPeds: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t…
RT @atscommunity: Treatment of Drug-Resistant Tuberculosis. An Official @atscommunity/@CDCgov/@EuroRespSoc /@IDSAInfo Clinical Practice Gui…
RT @ATSPeds: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/kYLhGIvLfa TA: @MSUPedsPulm https://t.co/3LZzTbGTpC
RT @atscommunity: Treatment of Drug-Resistant Tuberculosis. An Official @atscommunity/@CDCgov/@EuroRespSoc /@IDSAInfo Clinical Practice Gui…
Treatment of Drug-Resistant Tuberculosis. An Official @atscommunity/@CDCgov/@EuroRespSoc /@IDSAInfo Clinical Practice Guideline: https://t.co/xw2TeoI5NN #MDR-TB
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA… https://t.co/CU18RjmRq9 #eprompt #respire
RT @some4mv: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/IoiOhYl8mX #SoMe4MV from ATSBlueEditor
RT @ATSPeds: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/LnMCH4FUwU TA:…
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/IoiOhYl8mX #SoMe4MV from ATSBlueEditor
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline https://t.co/LnMCH4FUwU TA: @MSUPedsPulm https://t.co/DPjUrYZTVs